We are live on
!
Find out more
BHC
Bowen Hanes & Co Portfolio holdings
AUM
$4.11B
1-Year Est. Return
41.61%
This Fund
S&P 500
This Quarter
Est. Return
+12.49%
1 Year Est. Return
+41.61%
3 Year Est. Return
+119.85%
5 Year Est. Return
+166.26%
10 Year Est. Return
+656.19%
AUM
$3.54B
AUM Growth
+$288M
(+8.9%)
Cap. Flow
-$56.4M
Cap. Flow
% of AUM
-1.59%
Top 10 Holdings %
Top 10 Hldgs %
24.1%
Holding
163
New
9
Increased
34
Reduced
73
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$40.2M |
| 2 |
Edwards Lifesciences
EW
|
+$27.7M |
| 3 |
FedEx
FDX
|
+$27.7M |
| 4 |
Intuit
INTU
|
+$27.2M |
| 5 |
Trimble
TRMB
|
+$26.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$36.8M |
| 2 |
Corning
GLW
|
+$34.6M |
| 3 |
Cisco
CSCO
|
+$33.1M |
| 4 |
Walmart Inc
WMT
|
+$32.7M |
| 5 |
Ericsson
ERIC
|
+$25.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.79% |
| 2 | Industrials | 17.08% |
| 3 | Financials | 13.45% |
| 4 | Healthcare | 11.18% |
| 5 | Consumer Staples | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Abbott
ABT
$183B
| $619K | 0.02% |
4,399
| – | – |
|
127
Bristol-Myers Squibb
BMY
$132B
| $592K | 0.02% |
9,490
| – | – |
|
128
Snap-on
SNA
$21.2B
| $570K | 0.02% |
2,645
| – | – |
|
129
Dow Inc
DOW
$21.7B
| $567K | 0.02% |
9,989
+3,000
| +43% | +$171K |
|
130
RTX Corp
RTX
$289B
| $558K | 0.02% |
6,485
-1,387
| -18% | -$121K |
|
131
IBM
IBM
$209B
| $536K | 0.02% |
4,010
-603
| -13% | -$75.6K |
|
132
Cummins
CMI
$87.3B
| $524K | 0.01% |
2,400
| – | – |
|
133
BHP
BHP
$218B
| $516K | 0.01% |
9,585
-15,189
| -61% | -$760K |
|
134
Chubb
CB
$135B
| $485K | 0.01% |
2,510
| – | – |
|
135
Novartis
NVS
$301B
| $415K | 0.01% |
4,745
| – | – |
|
136
TSMC
TSM
$2.09T
| $401K | 0.01% |
3,330
| – | – |
|
137
AbbVie
ABBV
$455B
| $365K | 0.01% |
2,695
| – | – |
|
138
GXO Logistics
GXO
$5.8B
| $363K | 0.01% |
+4,000
| New | +$359K |
|
139
Estee Lauder
EL
$30.7B
| $357K | 0.01% |
965
| – | – |
|
140
Brookfield Infrastructure
BIPC
$5.24B
| $349K | 0.01% |
7,676
| – | – |
|
141
Mondelez International
MDLZ
$80.5B
| $344K | 0.01% |
5,185
| – | – |
|
142
Unilever
UL
$141B
| $336K | 0.01% |
5,554
| – | – |
|
143
Aon
AON
$77.8B
| $334K | 0.01% |
1,110
| – | – |
|
144
FNB Corp
FNB
$6.76B
| $330K | 0.01% |
27,216
-9,720
| -26% | -$117K |
|
145
Eaton
ETN
$150B
| $328K | 0.01% |
1,900
| – | – |
|
146
Leggett & Platt
LEG
$1.37B
| $322K | 0.01% |
7,831
| – | – |
|
147
Agilent Technologies
A
$39.2B
| $321K | 0.01% |
2,010
| – | – |
|
148
Capital One
COF
$129B
| $315K | 0.01% |
2,174
| – | – |
|
149
GE Aerospace
GE
$368B
| $305K | 0.01% |
5,183
-627
| -11% | -$39.4K |
|
150
Intel
INTC
$460B
| $288K | 0.01% |
5,601
| – | – |
|
Similar funds
AP
BOK
SP
GCM
MGP
CA
ZP
SHCM
Bowen Hanes & Co's Q4 2021 Portfolio in Review
As of Q4 2021, Bowen Hanes & Co held 163 positions worth $3.54B, up 8.9% from $3.26B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Bowen Hanes & Co's Q4 2021 filing shows 9 new, 34 increased, 73 reduced and 4 closed positions. Its largest new stake was Eli Lilly: 158,725 shares worth $43.8M. The largest sale was Medtronic, an estimated $36.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Industrials and Financials.
- Bowen Hanes & Co's largest Q4 2021 buy was Eli Lilly: 158,725 shares worth $43.8M.
- Bowen Hanes & Co added most to FedEx in Q4 2021, an estimated $27.7M increase.
- Bowen Hanes & Co's biggest Q4 2021 reduction was Medtronic, cutting an estimated $36.8M.
- Bowen Hanes & Co fully exited Sonos in Q4 2021, selling an estimated $17.8M.
- Bowen Hanes & Co's ten largest holdings make up 24% of its $3.54B portfolio in Q4 2021.
- Bowen Hanes & Co opened 9 new positions and closed 4 in Q4 2021.
- Bowen Hanes & Co's portfolio value rose 8.9% quarter-over-quarter to $3.54B.
Based on Bowen Hanes & Co's 13F filing for Q4 2021, filed 11 Feb 2022.